Updated:
Bioverge
San Francisco-based Bioverge invests in early-stage startups melding biology and tech, per Altss research.
Bioverge
Bioverge is an SEC-registered investment adviser with offices in Mill Valley, CA. It advises clients on investments. Bioverge specializes in the life sciences sector.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Mill Valley
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
What does Bioverge invest in?
Bioverge's mandate targets early-stage healthcare startups operating at the intersection of biology and technology. The firm focuses on digital health tools, precision medicine, and other innovations that use data to improve biological outcomes, per Altss research on its stated strategy.
Who runs Bioverge?
Publicly available inputs do not name any principals or investment team members at Bioverge. The firm has not disclosed its leadership structure on its main website or in widely available filings.
Is Bioverge a family office or a traditional venture firm?
Per Altss research, Bioverge is structured as an asset manager, not a single-family office. It operates as a private equity firm raising external capital rather than deploying a single family's wealth.
What stage does Bioverge typically target?
The firm invests at the early stage, specifically in startups at the startup and early venture phases. This includes seed and Series A rounds, focusing on companies still building their foundational technology.
How large is Bioverge and how much has it deployed?
Bioverge's assets under management and total capital deployed are undisclosed. The firm has not published these metrics in any source available to Altss research, making its scale publicly opaque.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: